BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary March 4, 2021 GlobeNewswire Source: Medical Share on Facebook Share Share on TwitterTweet Share on Google Plus Share Share on Pinterest Share Share on LinkedIn Share Share on Digg Share